AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer

Clinical trial NCT06591520 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06591520
Sponsor: Akeso
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2024-10-20
Primary completion: 2026-10-01
Enrollment: 682

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.